Chase Investment Counsel Corp
Source: SEC Form 13F · as of Mar 2026Chase Investment Counsel Corp holds 18 biotech & pharma companies tracked by BioSniper, totaling $31K in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$31K
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 30,581 | $7K |
| MCKMcKesson Corporation | 6,391 | $6K |
| CORCencora Inc. | 12,511 | $4K |
| UTHRUNITED THERAPEUTICS Corp | 4,400 | $3K |
| HALOHALOZYME THERAPEUTICS, INC. | 26,000 | $2K |
| INVAInnoviva, Inc. | 70,000 | $2K |
| LNTHLantheus Holdings, Inc. | 20,000 | $2K |
| CPRXCATALYST PHARMACEUTICALS, INC. | 60,000 | $1K |
| HRMYHarmony Biosciences Holdings, Inc. | 50,000 | $1K |
| JNJJOHNSON & JOHNSON | 4,622 | $1K |
| CAHCardinal Health Inc. | 3,578 | $756 |
| MRKMerck & Co., Inc. | 6,224 | $748 |
| GILDGILEAD SCIENCES, INC. | 5,121 | $713 |
| AMGNAMGEN INC | 1,709 | $601 |
| LLYELI LILLY & Co | 307 | $281 |
| BMYBRISTOL MYERS SQUIBB CO | 3,838 | $232 |
| WSTWest Pharmaceutical Services Inc. | 874 | $219 |
| VYGRVoyager Therapeutics, Inc. | 19,800 | $76 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.